2023: The Year in Medicine
Time|December 25, 2023
Drugs for obesity, Alzheimer's, and infectious diseases herald a new era of innovation in the pharma business
- By Alice Park
2023: The Year in Medicine

It's been a while since the pharmaceutical industry last saw a year like 2023, when the U.S. Food and Drug Administration (FDA) approved a slew of groundbreaking and life-changing medications that represent a surge in innovation-and a potential boon to the drugmakers' bottom lines.

Eisai and Biogen kicked off the year with the approval of lecanemab (Leqembi) for Alzheimer's disease, which is the second medication designed to treat the root causes of the memory-robbing condition, but appears to be the most effective. GSK and Pfizer dropped the first-ever vaccines for RSV in adults, giving older and pregnant people a way to protect themselves and, in the case of expectant mothers, their newborns as well-from a potentially deadly respiratory disease. Biogen and Sage Therapeutics received approval for a first-ever oral treatment for postpartum depression, zuranolone (Zurzuvae), and the FDA also allowed biotech companies Intellia Therapeutics and Regeneron Pharmaceuticals to start late-stage testing of the first gene-editing treatment, using CRISPR technology, inside patients.

この蚘事は Time の December 25, 2023 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

この蚘事は Time の December 25, 2023 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

TIMEのその他の蚘事すべお衚瀺
A timely thriller for a mad, mad world
Time

A timely thriller for a mad, mad world

A’70s-style paranoid thriller grounded in the partisan polarization of today

time-read
2 分  |
December 09, 2024
Freshwater reserves
Time

Freshwater reserves

A troubling dip

time-read
1 min  |
December 09, 2024
An exuberant ode to human possibility
Time

An exuberant ode to human possibility

VERY RARELY DOES THE RIGHT MOVIE ARRIVE AT precisely the right time, at a moment when compassion is in short supply and the collective human imagination has come to feel shrunken and desiccated.

time-read
3 分  |
December 09, 2024
Broadcasting a crisis for the world to see
Time

Broadcasting a crisis for the world to see

ON SEPT. 5, 1972, A 32-YEAR-OLD PRODUCER NAMED Geoffrey S. Mason was working in a control room for ABC Sports in Munich while 12 hostages, including several members of the Israeli Olympic delegation, were being held in a building nearby.

time-read
4 分  |
December 09, 2024
The Power of the Peer
Time

The Power of the Peer

WITH MENTAL-HEALTH CARE IN SHORT SUPPLY, CAN REGULAR PEOPLE FILL THE GAP?

time-read
7 分  |
December 09, 2024
QUEERING THE STORY
Time

QUEERING THE STORY

Luca Guadagnino directs Daniel Craig in an adaptation of William S. Burroughs' 1985 novella Queer

time-read
6 分  |
December 09, 2024
Shopping under the influence
Time

Shopping under the influence

LTK CO-FOUNDER AMBER VENZ BOX SAW THE FUTURE OF RETAIL. IT TOOK YEARS FOR THE REST OF THE WORLD TO CATCH UP

time-read
10+ 分  |
December 09, 2024
The Kingmaker
Time

The Kingmaker

Elon Musk's partnership with the President-elect

time-read
10+ 分  |
December 09, 2024
Turkey's Erdogan plots his next power grab
Time

Turkey's Erdogan plots his next power grab

RECEP TAYYIP Erdogan is a political survivor.

time-read
2 分  |
December 09, 2024
Why maiden names matter in the age of AI and identity
Time

Why maiden names matter in the age of AI and identity

IN THE DIGITAL AGE, A NAME IS MORE THAN JUST A label. It's tied to our professional history and social media presence.

time-read
2 分  |
December 09, 2024